E-LIB Suche - Ergebnisse für: Hilas, Olga

1

Intranasal Theophylline: Potential Treatment for Long COVID..:

Hilas, Olga ; Caliendo, Tina
Annals of Pharmacotherapy. , 2023

2

Pandemic Readiness: Disparities Among New York City Residen..:

Gunness, Harlem ; Jacob, Elsen ; Bhuiyan, Jennifer.
Disaster Medicine and Public Health Preparedness. 17 (2023) - p. , 2023

Link: https://doi.org/10.1017/..

3

α-Adrenergic Blockers for the Treatment of Lower-Urinary-Tr..:

Boyd, Katie ; Hilas, Olga
Annals of Pharmacotherapy. 48 (2014) 6 - p. 711-722 , 2014

Link: https://doi.org/10.1177/..

4

Rifaximin for the treatment of hepatic encephalopathy:

de Melo, Rachel Tavares ; Charneski, Lisa ; Hilas, Olga
American Journal of Health-System Pharmacy. 65 (2008) 9 - p. 818-822 , 2008

Link: https://doi.org/10.2146/..

5

Lamotrigine-induced Stevens-Johnson syndrome:

Hilas, Olga ; Charneski, Lisa
American Journal of Health-System Pharmacy. 64 (2007) 3 - p. 273-275 , 2007

Link: https://doi.org/10.2146/..

6

Abatacept: A Novel Agent for Rheumatoid Arthritis:

Sheth, Neha U ; Hilas, Olga ; Charneski, Lisa
Journal of Pharmacy Technology. 22 (2006) 6 - p. 336-341 , 2006

Link: https://doi.org/10.1177/..

7

Progress of Veterans Affairs pharmacies toward goals and ob..:

Favale, Maria ; Lovly, Ronald ; Reiter, Arthur.
American Journal of Health-System Pharmacy. 62 (2005) 13 - p. 1385-1387 , 2005

Link: https://doi.org/10.2146/..

8

Continuous Glucose Monitoring: A Review of Available System:

Funtanilla, Vienica D ; Candidate, PharmD ; Caliendo, Tina.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705487/. , 2019

Link: http://www.ncbi.nlm.nih...

9

Zarxio (Filgrastim-sndz): The First Biosimilar Approved by ..:

Awad, Mina ; Singh, Pavit ; Hilas, Olga
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215272/. , 2017

Link: http://www.ncbi.nlm.nih...

10

Edoxaban: an Investigational Factor Xa Inhibitor:

Hughes, Gregory J ; Hilas, Olga
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

11

Canagliflozin (Invokana), a Novel Oral Agent For Type-2 Dia..:

Sarnoski-Brocavich, Sheila ; Hilas, Olga
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875253. , 2013

Link: http://www.ncbi.nlm.nih...

12

Bapineuzumab, an Investigational Agent For Alzheimer's Dise..:

Khorassani, Farah ; Hilas, Olga
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628177. , 2013

Link: http://www.ncbi.nlm.nih...

13

Lupus: An Overview of the Disease And Management Options:

Maidhof, William ; Hilas, Olga
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351863. , 2012

Link: http://www.ncbi.nlm.nih...

14

Belimumab (Benlysta): A Breakthrough Therapy for Systemic L..:

Lamore, Raymond ; Parmar, Sapna ; Patel, Khilna.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351861. , 2012

Link: http://www.ncbi.nlm.nih...

15

Disease Modifying Agents for Multiple Sclerosis:

Hilas, Olga ; Patel, Priti N ; Lam, Sum
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024587. , 2010

Link: http://www.ncbi.nlm.nih...